Commitments and Contingencies (Details Textual) - USD ($) |
1 Months Ended | 3 Months Ended | 6 Months Ended | 12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
Jan. 14, 2014 |
Jan. 31, 2014 |
Dec. 31, 2015 |
Dec. 31, 2014 |
Dec. 31, 2015 |
Dec. 31, 2014 |
Jun. 30, 2015 |
Sep. 01, 2014 |
Dec. 30, 2013 |
Sep. 30, 2013 |
|
| Commitments and Contingencies [Line Items] | ||||||||||
| Research and Development Expense, Total | $ 704,000 | $ 731,000 | $ 1,255,000 | $ 1,916,000 | ||||||
| Long Term Purchase Commitment Expire Date | Dec. 31, 2015 | |||||||||
| Settlement Liabilities, Current | 1,875,000 | $ 1,875,000 | ||||||||
| iBio CMO LLC [Member] | New Lease [Member] | ||||||||||
| Commitments and Contingencies [Line Items] | ||||||||||
| Sale Leaseback Transaction, Quarterly Rental Payments | $ 2,100,000 | |||||||||
| Gross Sales Description | In addition to the base rent, iBio CMO is required to pay, for each calendar year during the term, a portion of the total gross sales for products manufactured or processed at the facility, equal to 7% of the first $5,000,000 of gross sales, 6% of gross sales between $5,000,001 and $25,000,000, 5% of gross sales between $25,000,001 and $50,000,000, 4% of gross sales between $50,000,001 and $100,000,000, and 3% of gross sales between $100,000,001 and $500,000,000. However, if for any calendar year period from January 1, 2018 through December 31, 2019, iBio CMOs applicable gross sales are less than $5,000,000, or for any calendar year period from and after January 1, 2020, its applicable gross sales are less than $10,000,000, then iBio CMO is required to pay the amount that would have been payable if it had achieved such minimum gross sales and shall pay no less than the applicable percentage for the minimum gross sales for each subsequent calendar year. | |||||||||
| Second Eastern Affilate [Member] | iBio CMO LLC [Member] | ||||||||||
| Commitments and Contingencies [Line Items] | ||||||||||
| Lease Term | 35 years | |||||||||
| Fraunhofer [Member] | ||||||||||
| Commitments and Contingencies [Line Items] | ||||||||||
| Research and Development Expense, Total | 119,000 | $ 367,000 | $ 279,000 | $ 1,186,000 | ||||||
| Royalty Guarantees, Commitments, Amount | 4,000,000 | 4,000,000 | $ 3,000,000 | |||||||
| Contractual Obligation | 3,000,000 | $ 3,000,000 | ||||||||
| Other Commitments, Description | Under the terms of the TTA (described in Note 6 Significant Vendor) and for a period of 15 years: 1) the Company shall pay Fraunhofer one percent (1%) of all receipts derived by the Company from sales of products produced utilizing the Technology and ten percent (10%) of all receipts derived by the Company from licensing the Technology to third parties. | |||||||||
| Commitments [Member] | ||||||||||
| Commitments and Contingencies [Line Items] | ||||||||||
| Research Services Agreements Value Fulfilling Commitment | $ 3,000,000 | |||||||||
| Termination of Research Services Agreement | $ 1,500,000 | |||||||||
| Research and Development Expense, Total | $ 500,000 | $ 210,000 | ||||||||
| Royalty Guarantees, Commitments, Amount | $ 4,000,000 | $ 4,000,000 | ||||||||
| License Costs | $ 30,627 | |||||||||
| Initial license fee | 20,000 | |||||||||
| Contractual Obligation, Due in Next Twelve Months | $ 78,000 | |||||||||
| Contractual Obligation, Due in Second Year | $ 161,754 | |||||||||
| Commitments [Member] | Minimum [Member] | ||||||||||
| Commitments and Contingencies [Line Items] | ||||||||||
| License Costs | 25,000 | |||||||||
| Commitments [Member] | Maximum [Member] | ||||||||||
| Commitments and Contingencies [Line Items] | ||||||||||
| License Costs | $ 150,000 | |||||||||